Panavance Therapeutics Inc. logo

Panavance Therapeutics Inc. jobs and careers

Berwyn, United States

About Panavance Therapeutics Inc.

Panavance Therapeutics Inc. is a US, clinical-stage pharmaceutical company established in 2021 by the Swiss-based Avensis Pharma AG, a subsidiary of Ed. Geistlich Söhne AG für Chemische Industrie. Panavance is focused on advancing the development of GP-2250, a novel oncology therapeutic intended to improve outcomes and quality of life for patients with cancer. With its highly capable team and strong academic and industry partnerships, Panavance is pursuing a rigorous program to bring GP-2250 to patients around the world.

Founded
2021
Employees
1 to 10
Headquarters
Berwyn

Leadership

The top of Panavance Therapeutics Inc.'s org chart, with how many people report into each leader.

JIPhoto of José Iglesias

José Iglesias

Chief Medical Officer

4 reports

BSPhoto of Ben Steinmetz

Ben Steinmetz

Chief Commercial Officer

THPhoto of Tom Hess

Tom Hess

Chief Financial Officer

CGPhoto of Carol Gorman

Carol Gorman

Executive Assistant

RHPhoto of Robert Hrubiec

Robert Hrubiec

Head, Intellectual Property & Patents

HMPhoto of Hanns Moehler

Hanns Moehler

Head, Pharmacology

ASPhoto of Alexander Smith

Alexander Smith

Head, CMC & Quality

DSPhoto of Duane Sofia

Duane Sofia

Head, Non-clinical Research

KMPhoto of Kathryn Martin

Kathryn Martin

Head, Scientific & Regulatory Communications

Jobs at Panavance Therapeutics Inc.

No open positions right now. Explore more companies on TheJobsMap.